Propranolol for Treatment of Cocaine Addiction - 2

This study has been completed.

First Received on September 20, 1999. Last Updated on February 3, 2010 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	University of Pennsylvania
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000197

Purpose

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Propranolol	Phase II

Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Propranolol for Treatment of Cocaine Addiction

Resource links provided by NLM:

MedlinePlus related topics: Anxiety

Drug Information available for: Cocaine hydrochloride Propranolol hydrochloride Propranolol Dexpropranolol

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Side effects
Cocaine use
Cocaine withdrawal
Cocaine craving
Mood and anxiety
Clinical improvement

Estimated Enrollment:	0
Study Start Date:	January 1987
Study Completion Date:	January 2002
Primary Completion Date:	January 2002 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	25 Years to 49 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000197

Locations

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Pennsylvania

Investigators

Principal Investigator:

Kyle Kampman, M.D.

University of Pennsylvania

More Information

No publications provided

Responsible Party:	Kyle Kampman, University of Pennsylvania
ClinicalTrials.gov Identifier:	NCT00000197 History of Changes
Other Study ID Numbers:	NIDA-00238-2, K20DA000238
Study First Received:	September 20, 1999
Last Updated:	February 3, 2010
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Propranolol
Anti-Arrhythmia Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions

Antihypertensive Agents
Adrenergic beta-Antagonists
Adrenergic Antagonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Vasodilator Agents

ClinicalTrials.gov processed this record on February 09, 2012